Sign in

CIK 0001159036

  • Large accelerated filer

HALOZYME THERAPEUTICS, INC.

Sign in to watch
Ticker
HALO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
880488686
Phone
+1 858-794-8889
Business address
12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
Former names
HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
  1. 4 Planned sale Director sold 1,625 shares at $66.21 ($107,591)
  2. 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $68.68 ($3,433,875)
  3. 4 Grant or award Director acquired 3,796 shares (grant or award)
  4. 4 Grant or award Director acquired 3,796 shares (grant or award)
  5. 4 Grant or award Director acquired 3,796 shares (grant or award)
  6. 4 Grant or award Director acquired 3,796 shares (grant or award)
  7. 4 Grant or award Director acquired 3,796 shares (grant or award)
  8. 4 Grant or award Director acquired 6,796 shares (grant or award)
  9. 4 Planned sale Director sold 1,625 shares at $63.48 ($103,155)
  10. 4 Planned sale PRESIDENT AND CEO sold 10,000 shares at an average $63.50 ($634,982)
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale PRESIDENT AND CEO sold 40,000 shares at an average $64.81 ($2,592,237)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale SVP, CHIEF OPERATING OFFICER sold 28,857 shares at an average $67.75 ($1,955,160)
  15. 4 Planned sale PRESIDENT AND CEO sold 50,000 shares at an average $69.52 ($3,476,157)
  16. 4 Shares withheld for taxes SVP, CHIEF OPERATING OFFICER gave up 1,037 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 6,658 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, CHIEF FINANCIAL OFFICER gave up 6,484 shares (to pay taxes)
  19. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 21,144 shares (to pay taxes)
  20. 4 Shares withheld for taxes SVP, CHIEF LEGAL OFFICER gave up 9,068 shares (to pay taxes)

Page 2 of 39 · 774 filings